Blood markers may spot diabetes risk after pregnancy
NCT ID NCT02133729
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study followed 255 women with gestational diabetes to see if simple blood tests during pregnancy could predict who will develop type 2 diabetes after giving birth. Researchers measured three markers (CRP, MDA, and adiponectin) and checked glucose tolerance three months after delivery. The goal is to focus follow-up care on women at highest risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors identify which women with gestational diabetes are at highest risk for type 2 diabetes, allowing earlier prevention efforts.
What could go wrong
This is an observational study, not a treatment trial. The markers tested may not prove accurate enough for routine use, and results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Clermont-Ferrand - Hôpital Gabriel Montpied - Service d'endocrinologie
Clermont-Ferrand, 63003, France
-
CHU Grenoble - Clinique d'Endocrinologie Diabétologie Nutrition
Grenoble, 38000, France
-
CHU Saint Etienne - Hôpital Nord - Service d'endocrinologie, diabètes, nutrition
Saint-Etienne, 42055, France
-
Centre Hospitalier de Givors - Hôpital de Montgelas - Service de médicine 8
Givors, 69700, France
-
Groupement Hospitalier des Portes du Sud - Service d'Endocrinologie Diabétologie Nutrition
Vénissieux, 69200, France
-
Hospices Civils de Lyon - Groupement Hospitalier Sud - Service d'Endocrinologie, Diabète, Nutrition
Pierre-Bénite, 69495, France
-
Hospices Civils de Lyon - Hôpital Femme-Mère-Enfant - Service de gynécologie obstétrique
Bron, 69677, France